UK
UK COVID-19 Extended Wave Spikes in 2022Back in 3 Nov, a month before Omicron was introduced to the world, it was described as:
" it is rising into 2022. Just how bad remains to be seen."
From the weekly chart... it's BAD.
Do remember (and check) that at the end of October, and early November, many thought that the cases were decreasing and although there was some expectations for an increase in winter, no one thought it would be this bad.
Enters Omicron and we are looking at new dynamics.
Do recall that previous projections noted an extended wave... Here it is.
Yet another example of the working of this projection model and it's effectiveness.
Take care and stay safe peeps!
RWS: Weekly uptrend remains stableAlthough RWS can be a volatile stock, we've seen the weekly support level is a strong one to add more positions. We sold SDL after the takeover announcement by RWS and then we bought it when it finished its correction in January 2021. It's a good one for the long-term not only by technical but also fundamentals, as translation software is growing in importance everyday and it has a good dividend yield.
Novacyt ALNOV They have marked the supports and resistances of ALNOV .
It has great upside potential, key level reaching $ 5
Last Friday news Clinical diagnostics specialist Novacyt announced on Friday thatots ‘genesig’ Covid-19 real-time PCR test has been approved in the UK. Great news and great upside potential.
A cordial greeting.
In Spain on 12/28/2021 L.E.D.
Wish you all the best and a happy New Year
Novacyt ALNOV They have marked the supports and resistances of ALNOV.
It has great upside potential, key level reaching $ 5
Last Friday news Clinical diagnostics specialist Novacyt announced on Friday thatots ‘genesig’ Covid-19 real-time PCR test has been approved in the UK.
I send you a cordial greeting, Merry Christmas and a prosperous 2022
In Spain on 12/23/2021